Wellbiotec Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 0.00001 million compared to KRW 0.00001 million a year ago. Net loss was KRW 520.62 million compared to net income of KRW 3,684.25 million a year ago.

Basic loss per share from continuing operations was KRW 8 compared to basic earnings per share from continuing operations of KRW 63 a year ago. Diluted loss per share from continuing operations was KRW 8 compared to diluted earnings per share from continuing operations of KRW 63 a year ago. Basic loss per share was KRW 8 compared to basic earnings per share of KRW 63 a year ago.